AOKI DIABETES RESEARCH INSTITUTE (EIN 680087787) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1986

Legal Domicile

Principal Officer

THOMAS AOKI MD

Phone

9164552374

Tax Period

2023-01-01 to 2023-12-31

AOKI DIABETES RESEARCH INSTITUTE, founded in 1986, is a small nonprofit that reported $113K in total revenue in fiscal year 2023. Expenses of $145K exceeded revenue, resulting in a 28% operating deficit.

Mission

THE PURPOSE OF ADRI SHALL BE TO ENGAGE IN MEDICAL RESEARCH, INCL BASIC AND CLINICAL INVESTIGATIONS INTO THE NATURE,DIAGNOSIS,TREATMENT & CURE OF METABOLIC DISORDERS SUCH AS DIABETES,INCLUDE THE MEDICAL TECH,SO THAT IT MAY BE MADE ABLE TO BE DELIVERED TO DIABETIC PEOPLE THE WORLD OVER.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $78,787

Program Service Revenue $32,107

Investment Income $1,725

Other Revenue $0

TOTAL REVENUE $112,619

Expense Breakdown

Grants Paid $0

Salaries & Benefits $59,737

Fundraising Expenses $0

Program Expenses $118,467

Other Expenses $84,937

TOTAL EXPENSES $144,674

Year-over-Year Comparison

	2023	2022	Change
Revenue	$112,619	$112,967	0.0%
Expenses	$144,674	$159,859	-0.1%
Net Income	$-32,055	$-46,892	-0.3%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
YASUO TAKEGOSHI	DIRECTOR	2.00	Director	$0	$0	$0
THOMAS AOKI MD	President & CEO	10.00	Officer Director	$0	$0	$0
ADELINE MUELLER	Secretary	20.00	Officer Director	$0	$0	$0
JOYCE JOHNSTON	Director	2.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$112,619	$144,674	$39,916	$-32,055
2022	$112,967	$159,859	$52,830	$-46,892
2021	$119,583	$415,015	$99,764	$-295,432
2020	$210,280	$204,502	$89,907	$5,778
2019	$189,985	$702,288	$47,751	$-512,303
2018	$167,385	$501,352	$60,660	$-333,967

AOKI DIABETES RESEARCH INSTITUTE